EGFR-IN-36 structure
|
Common Name | EGFR-IN-36 | ||
---|---|---|---|---|
CAS Number | 2711105-54-1 | Molecular Weight | 488.97 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C26H25ClN6O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of EGFR-IN-36EGFR-IN-36 is a potent EGFR inhibitor with IC50s of 19.09 nM, 120.01 nM, 2.35 nM for EGFR (WT), HER2 (WT), HER2 (A775_G776insYVMA), respectively. EGFR-IN-36 has potential for wild and/or mutant EGFR and/or HER2 kinase mediated tumors research[1]. |
Name | EGFR-IN-36 |
---|
Description | EGFR-IN-36 is a potent EGFR inhibitor with IC50s of 19.09 nM, 120.01 nM, 2.35 nM for EGFR (WT), HER2 (WT), HER2 (A775_G776insYVMA), respectively. EGFR-IN-36 has potential for wild and/or mutant EGFR and/or HER2 kinase mediated tumors research[1]. |
---|---|
Related Catalog | |
Target |
EGFR (WT):19.09 nM (IC50) HER2(WT):120.01 nM (IC50) HER2 (A775_G776insYVMA):2.35 nM (IC50) |
In Vitro | EGFR-IN-36 (compound 8) inhibits A431 cell (IC50=223.6 nM),A549 cell (IC50=7644.42 nM), H1975 cell (IC50=20.68 nM)[1]. |
References |
Molecular Formula | C26H25ClN6O2 |
---|---|
Molecular Weight | 488.97 |